The Discounted Cash Flow (DCF) valuation of Global Blood Therapeutics Inc (GBT) is (613.46) USD. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on DCF is -995.7%.
Based on the latest price of 68.49 USD and our DCF valuation, Global Blood Therapeutics Inc (GBT) is a sell. selling GBT stocks now will result in a potential gain of 995.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.0% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,484.06) - (395.17) | (613.46) |
| Upside | -2266.8% - -677.0% | -995.7% |